DOI Services Persistent Identifiers for Scholarly Research
You are viewing the preserved copy. Open the article on the journal's website →

International Journal Of Clinical Pharmacology And Medical Sciences • pp. 1-12

CLINICAL EVALUATION OF DRUG SAFETY AND ADVERSE REACTIONS

  • Kinza Abdul Star BS, Department of English, The Cosmic Degree College (For Women) ,University of Okara

Abstract

Drug safety is an essential component of modern clinical pharmacology because the appropriate use of medications

directly influences patient health, treatment effectiveness, and overall healthcare quality. Although pharmaceutical

treatments provide significant benefits in preventing and managing diseases, their use may also produce adverse

drug reactions that can negatively affect patients and create additional healthcare challenges. Adverse drug

reactions may occur because of inappropriate dosages, genetic variations, drug interactions, individual biological

characteristics, and unexpected responses to pharmaceutical substances. Clinical evaluation of drug safety involves

examining the benefits, risks, effectiveness, and possible complications associated with medication use. Modern

pharmacological research increasingly focuses on identifying potential safety concerns through clinical trials,

pharmacovigilance systems, laboratory investigations, and post-marketing surveillance. This research examines the

clinical evaluation of drug safety and adverse reactions, emphasizing their importance in improving patient

protection and strengthening rational medication practices. It also investigates the major causes of adverse drug

reactions, methods of identifying medication-related risks, and the role of healthcare professionals in preventing

avoidable complications. The study adopts a qualitative research methodology based on secondary academic

literature and published scientific investigations. The findings indicate that effective drug safety evaluation requires

continuous monitoring, accurate reporting, evidence-based prescribing, and cooperation among healthcare

professionals. Advanced technologies and improved pharmacovigilance systems can further strengthen the

identification and management of medication-related risks. However, underreporting, inadequate professional

awareness, complex drug interactions, and limitations in monitoring systems remain significant challenges. The

research concludes that comprehensive clinical evaluation and continuous pharmacovigilance are essential for

ensuring safer medication use and improving patient-centered healthcare.

Record

Identifier
https://doi-services.com/1141/232
Published
2026-09-08
Version
1
Original
https://studentsconsultancyhome.com/season-2/journal/index.php/IJCPMS/article/view/232